Cargando…

Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?

This letter reflects on the PALOMA‐3 study, as related to the safety analysis of premenopausal breast cancer patients.

Detalles Bibliográficos
Autor principal: Altundag, Kadri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469593/
https://www.ncbi.nlm.nih.gov/pubmed/28611237
http://dx.doi.org/10.1634/theoncologist.2016-0446
_version_ 1783243606239215616
author Altundag, Kadri
author_facet Altundag, Kadri
author_sort Altundag, Kadri
collection PubMed
description This letter reflects on the PALOMA‐3 study, as related to the safety analysis of premenopausal breast cancer patients.
format Online
Article
Text
id pubmed-5469593
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-54695932017-07-13 Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning? Altundag, Kadri Oncologist Letters to the Editor This letter reflects on the PALOMA‐3 study, as related to the safety analysis of premenopausal breast cancer patients. AlphaMed Press 2017-06-12 2017-06 /pmc/articles/PMC5469593/ /pubmed/28611237 http://dx.doi.org/10.1634/theoncologist.2016-0446 Text en © AlphaMed Press 2017
spellingShingle Letters to the Editor
Altundag, Kadri
Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?
title Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?
title_full Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?
title_fullStr Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?
title_full_unstemmed Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?
title_short Safety Analysis of Premenopausal Breast Cancer Patients in PALOMA‐3 Study: Is It Worth Mentioning?
title_sort safety analysis of premenopausal breast cancer patients in paloma‐3 study: is it worth mentioning?
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469593/
https://www.ncbi.nlm.nih.gov/pubmed/28611237
http://dx.doi.org/10.1634/theoncologist.2016-0446
work_keys_str_mv AT altundagkadri safetyanalysisofpremenopausalbreastcancerpatientsinpaloma3studyisitworthmentioning